{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:57:42Z","timestamp":1761541062529},"publisher-location":"Boston, MA","reference-count":23,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461380016"},{"type":"electronic","value":"9781461303312"}],"license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/978-1-4613-0331-2_7","type":"book-chapter","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T05:05:28Z","timestamp":1316754328000},"page":"87-92","source":"Crossref","is-referenced-by-count":43,"title":["Antibodies to von Willebrand factor in von Willebrand disease"],"prefix":"10.1007","author":[{"given":"P. M.","family":"Mannucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. B.","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0049-3848(79)90229-9","volume":"16","author":"AL Bloom","year":"1979","unstructured":"Bloom AL, Peake IR, Furlong RA and Davies BL. High potency factor VIII concentrate: more effective than cryoprecipitate in a patient with von Willebrand\u2019s disease and inhibitor. Thromb Res 16: 847 (1979).","journal-title":"Thromb Res"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0049-3848(76)90209-7","volume":"9","author":"N Egberg","year":"1976","unstructured":"Egberg N and Blomback M. On the characterization of acquired inhibitors to ristocetin-induced platelet aggregation found in patients with von Willebrand\u2019s disease. Thromb Res 9: 527 (1976).","journal-title":"Thromb Res"},{"key":"7_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0038-1651576","volume":"69","author":"D Ginsburg","year":"1993","unstructured":"Ginsburg D and Sadler JE. von Willebrand disease: a database of point mutations, insertions and deletions. Thromb Haemostas 69: 177 (1993).","journal-title":"Thromb Haemostas"},{"key":"7_CR4","first-page":"224","volume":"62","author":"WT Hanna","year":"1989","unstructured":"Hanna WT. Replacement therapy for surgery in type III von Willebrand patient with inhibitors to factor VIII procoagulant. Thromb Haemostas 62: 224 (1989) (abstract).","journal-title":"Thromb Haemostas"},{"key":"7_CR5","first-page":"826","volume":"105","author":"H Lenk","year":"1978","unstructured":"Lenk H, Weissbach G and Donula M. Ein Hemmkorper bei von Willebrand Jurgens- Syndrome and seine Wirkung aur die Eigenschaften des Factor VIII molekuls. Folia Haematol 105: 826 (1978).","journal-title":"Folia Haematol"},{"key":"7_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood.V72.1.116.bloodjournal721116","volume":"72","author":"MF Lopez-Fernandez","year":"1988","unstructured":"Lopez-Fernandez MF, Martin R, Lopez-Berges C, Ramos F, de Bosch N and Battle J. Further specific characterization of von Willebrand factor inhibitors developed in two patients with severe von Willebrand disease. Blood 72: 116 (1988).","journal-title":"Blood"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1182\/blood.V72.1.116.bloodjournal721116","volume":"72","author":"MF Lopez-Fernandez","year":"1988","unstructured":"Lopez-Fernandez MF, Martin R, Lopez-Berges C, Ramos F, de Bosch N and Battle J. Further specific characterization of von Willebrand factor inhibitors developed in two patients with severe von Willebrand disease. Blood 72: 116 (1988).","journal-title":"Blood"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/262141a0","volume":"262","author":"PM Mannucci","year":"1976","unstructured":"Mannucci PM, Meyer D, Ruggeri ZM, Koutts J, Ciavarella N and Lavergne JM. Precipitating antibodies in von Willebrand\u2019s disease. Nature 262: 141 (1976).","journal-title":"Nature"},{"key":"7_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V57.1.25.25","volume":"57","author":"PM Mannucci","year":"1981","unstructured":"Mannucci PM, Ruggeri ZM, Ciavarella N, Kazatchkine MD and Mowbray JF. Precipitating antibodies to factor VIII-von Willebrand factor in von Willebrand\u2019s disease: effects on replacement therapy. Blood 57: 25 (1981).","journal-title":"Blood"},{"key":"7_CR10","first-page":"109","volume-title":"Factor Villi inhibitors","author":"PM Mannucci","year":"1984","unstructured":"Mannucci PM and Mari D. Antibodies to factor VTII\/von Willebrand factor in congenital and acquired von Willebrand\u2019s disease. In: LW Hoyer ed. Factor Villi inhibitors. New York: Alan R. Liss, 109 (1984)."},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2141.1984.tb02876.x","volume":"57","author":"PM Mannucci","year":"1984","unstructured":"Mannucci PM, Bloom A, Larrieu MJ, Nilsson IM and West RR. Atherosclerosis and von Willebrand factor. Prevalence of severe von Willebrand disease in Western Europe and Israel. Br J Haematol 57: 166 (1984).","journal-title":"Br J Haematol"},{"key":"7_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1600-0609.1987.tb01458.x","volume":"39","author":"PM Mannucci","year":"1987","unstructured":"Mannucci PM, Tamaro G, Nerchi G, Candotti G, Federici A, Altieri D and Tedesco F. Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor. Eur J Hematol 39: 467 (1987).","journal-title":"Eur J Hematol"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF02919121","volume":"21","author":"PM Mannucci","year":"1991","unstructured":"Mannucci PM and Cattaneo M. Alloantibodies in congenital von Willebrand disease. Res Clin Lab 21: 119 (1991).","journal-title":"Res Clin Lab"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0049-3848(79)90257-3","volume":"14","author":"S Maragall","year":"1979","unstructured":"Maragall S, Castillo R, Ordinas A, Iiendo F and Rodriquez M. Inhibition of Willebrand factor in von Willebrand\u2019s disease. Thromb Res 14: 495 (1979).","journal-title":"Thromb Res"},{"key":"7_CR15","first-page":"34","volume":"50","author":"CH Miller","year":"1983","unstructured":"Miller CH, Bussel JB and Hilgartner MW. Characteristics of inhibitors in severe von Willebrand\u2019s disease. Thromb Haemost 50: 34 (1983) (abstract).","journal-title":"Thromb Haemost"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1073\/pnas.85.8.2753","volume":"85","author":"K Ngo","year":"1988","unstructured":"Ngo K, Glotz VT, Koziol JA, et al. Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand\u2019s disease. Proc Natl Acad Sci USA 85: 2753 (1988).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR17","first-page":"6544","volume":"72","author":"IR Peake","year":"1990","unstructured":"Peake IR, Lidde CB, Moodie P, et al. Severe type III von Willebrand\u2019s disease caused by deletion of exon 42 of the von Willebrand factor gene: family studies that identify carriers of the condition and a compound heterozygous individual. Blood 72: 6544 (1990).","journal-title":"Blood"},{"key":"7_CR18","first-page":"60","volume":"94","author":"ZM Ruggeri","year":"1979","unstructured":"Ruggeri ZM, Ciavarella N, Mannucci PM, Molinari A, Dammaco F, Lavergne JM and Meyer D. Familial incidence of precipitating antibodies in von Willebrand\u2019s disease: a study of four cases. J Lab. Clin Med 94: 60 (1979).","journal-title":"J Lab. Clin Med"},{"key":"7_CR19","first-page":"2937","volume":"71","author":"KE Sarji","year":"1974","unstructured":"Sarji KE, Stratton RD, Wagner RH and Brinkhous KM. Nature of von Willebrand factor. A new assay and a specific inhibitor. Proc Natl Acad Sci USA 71: 2937 (1974).","journal-title":"Nature of von Willebrand factor. A new assay and a specific inhibitor. Proc Natl Acad Sci USA"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1172\/JCI112974","volume":"79","author":"BB Shelton-Inloes","year":"1987","unstructured":"Shelton-Inloes BB, Chebab FF, Mannucci PM, Federici AB and Sadler JE. Gene deletions correlate with the development of antibodies in von Willebrand disease. J Clin Invest 79: 1459 (1987).","journal-title":"J Clin Invest"},{"key":"7_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2141.1977.tb08812.x","volume":"37","author":"I Shoa\u2019i","year":"1977","unstructured":"Shoa\u2019i I, Lavergne JM, Ardaillou N, Obert B, Ala F and Meyer D. Heterogeneity of von Willebrand\u2019s disease; study of 40 Iranian cases. Br J Haematol 37: 67 (1977).","journal-title":"Br J Haematol"},{"key":"7_CR22","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1073\/pnas.72.10.4167","volume":"72","author":"RD Stratton","year":"1975","unstructured":"Stratton RD, Wagner RH, Webster WP and Brinkhous KM. Antibody nature of circulating inhibitor of plasma von Willebrand factor. Proc Natl Acad Sci USA 72: 4167 (1975).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR23","first-page":"850","volume":"51","author":"ZP Zhang","year":"1992","unstructured":"Zhang ZP, Lindstedt M, Falk G, Blomback M, Egberg N and Anvret M. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and I. Am J Hum Genet 51: 850 (1992).","journal-title":"Am J Hum Genet"}],"container-title":["Advances in Experimental Medicine and Biology","Inhibitors to Coagulation Factors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4613-0331-2_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T06:49:56Z","timestamp":1580366996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4613-0331-2_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"ISBN":["9781461380016","9781461303312"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-1-4613-0331-2_7","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1995]]}}}